Related Experiment Video
Updated: Jan 19, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Evidence for Healing Diabetic Foot Ulcers With Biologic Skin Substitutes: A Systematic Review and Meta-Analysis
Alex J Gordon1, Allyson R Alfonso1, Joey Nicholson2
1From the Hansjörg Wyss Department of Plastic Surgery, New York University Langone Health.
Background:
Development of diabetic foot ulcers is a common complication of diabetes. Standard-of-care (SOC) therapy alone is often not sufficient to heal these wounds, resulting in application of adjuvant wound therapies including biologic skin substitutes. Although a variety of products exist, it has been difficult to formulate conclusions on their clinical efficacy. We therefore performed a systematic review and meta-analysis on the efficacy of healing diabetic foot ulcers with biologic skin substitutes.
Methods:
A systematic review was conducted in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). Four electronic databases (PubMed/MEDLINE, EMBASE [Ovid], Cochrane CENTRAL [Ovid], and Web of Science) were searched from inception through February 27, 2019. Searches included keywords and subject headings pertaining to 3 main concepts: biologic skin substitutes, wound healing, and diabetic foot ulcers. Cochrane randomized controlled trial filters were used to narrow results. Data were extracted from 54 included articles, and risk-of-bias assessments were conducted by 2 independent reviewers. The primary objective was to calculate a pooled risk ratio for the proportion of wounds completely closed by 12 weeks. Secondary objectives included a pooled risk ratio for the proportion of wounds completely closed by 6 weeks and mean time to healing.
Results:
Twenty-five studies were identified that assessed the proportion of complete wound closure by 12 weeks. We found that wounds treated with biologic dressings were 1.67 times more likely to heal by 12 weeks than those treated with SOC dressings (P < 0.00001). Five studies assessed the proportion of complete wound closure by 6 weeks. Wounds treated with biologic dressings were 2.81 times more likely to heal by 6 weeks than those treated with SOC dressings (P = 0.0001). Descriptively, 29 of 31 studies that assessed time to healing favored biologic dressings over SOC dressings.
Conclusions:
This systematic review provides supporting evidence that biologic skin substitutes are more effective than SOC dressings at healing diabetic foot ulcers by 12 weeks. Future studies must address the relative benefits of different skin substitutes as well as the long-term implications of these products and their financial considerations.
Insights
Biologic skin substitutes significantly improve healing for diabetic foot ulcers compared to standard care. These advanced wound therapies show a 1.67x higher healing rate by 12 weeks, offering a promising adjuvant treatment.
Area of Science:
- Wound Healing Research
- Biomaterials in Medicine
- Diabetes Complications Management
Background:
- Diabetic foot ulcers (DFUs) are a common and serious complication of diabetes.
- Standard-of-care (SOC) therapy alone is often insufficient for DFU healing.
- Adjuvant therapies, including biologic skin substitutes, are frequently used but their efficacy is debated.
Purpose of the Study:
- To systematically review and meta-analyze the efficacy of biologic skin substitutes for healing diabetic foot ulcers.
- To compare the healing rates of DFUs treated with biologic skin substitutes versus SOC therapy.
- To evaluate secondary outcomes such as healing time and closure rates at different time points.
Main Methods:
- Systematic review and meta-analysis conducted following PRISMA guidelines.
- Searched four major electronic databases (PubMed/MEDLINE, EMBASE, Cochrane CENTRAL, Web of Science) up to February 27, 2019.
- Included studies focused on biologic skin substitutes, wound healing, and diabetic foot ulcers, with risk-of-bias assessments performed.
Main Results:
- Biologic dressings were associated with a 1.67 times higher likelihood of complete wound closure by 12 weeks (P < 0.00001).
- Healing by 6 weeks was also significantly improved, with biologic dressings being 2.81 times more likely to achieve closure (P = 0.0001).
- Descriptive analysis of 29 studies favored biologic dressings for faster time to healing compared to SOC.
Conclusions:
- Biologic skin substitutes demonstrate superior efficacy over standard-of-care dressings for healing diabetic foot ulcers within 12 weeks.
- Further research is needed to compare different types of skin substitutes and assess long-term outcomes and cost-effectiveness.
- This review provides evidence supporting the use of biologic skin substitutes as an effective adjuvant therapy for DFUs.
Related Concept Videos
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Foot Exam
The foot is a complex structure composed of numerous bones and articulations. It provides flexibility, is the essential contact point needed for ambulation, and is uniquely suited to absorb shock. Because the foot must support the weight of the entire body, it is prone to injury and pain. When examining the foot, it is important to remove shoes and socks on both sides, so that the entire foot can be inspected and...
08:06Creation and Transplantation of an Adipose-derived Stem Cell (ASC) Sheet in a Diabetic Wound-healing Model
10:49Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
